# Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.

> **NCT01283152** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Hepatic Encephalopathy
- Cirrhosis
- Portosystemic Encephalopathy
- PSE

## Interventions

- **DRUG:** Polyethylene glycol 3350-electrolyte solution (GoLYTELY®)
- **DRUG:** Lactulose

## Key facts

- **NCT ID:** NCT01283152
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283152, "Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01283152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*